Most popular

Is there an antiviral treatment approved by the FDA for use in COVID-19?

Is there an antiviral treatment approved by the FDA for use in COVID-19?

In October 2020, the FDA approved the antiviral drug remdesivir to treat COVID-19. The drug may be used to treat adults and children ages 12 and older and weighing at least 88 pounds, who have been hospitalized for COVID-19. Clinical trials suggest that in these patients, remdesivir may modestly speed up recovery time.

Is remdesivir used to treat COVID-19?

Remdesivir injection is used to treat coronavirus disease 2019 (COVID-19 infection) caused by the SARS-CoV-2 virus in hospitalized adults and children 12 years of age and older who weigh at least 88 pounds (40 kg). Remdesivir is in a class of medications called antivirals.

What is the virus that causes COVID-19?

SARS-CoV-2 stands for severe acute respiratory syndrome coronavirus 2. SARS-CoV-2 is the strain of coronavirus that causes the COVID-19 disease.

Is COVID-19 caused by a virus or a bacteria?

The coronavirus disease (COVID-19) is caused by a virus, NOT by bacteria.

What kind of virus is used to treat cancer?

Known as oncolytic viruses, this group includes viruses found in nature as well as viruses modified in the laboratory to reproduce efficiently in cancer cells without harming healthy cells.

What are the most promising targets for cancer treatment?

Since last few years, many promising drug targets have been identified for the effective treatment of cancer. The current review article describes some of these promising anticancer targets that include kinases, tubulin, cancer stem cells, monoclonal antibodies and vascular targeting agents.

Are there any genetically modified viruses for cancer?

To date, only one oncolytic virus—a genetically modified form of a herpesvirus for treating melanoma—has been approved by the Food and Drug Administration (FDA), though a number of viruses are being evaluated as potential treatments for cancer in clinical trials.

Which is the biggest problem in the development of anti cancer drugs?

The biggest problem in the anticancer drug development is acquiring of multidrug resistance and relapse. Classical chemotherapeutics directly target the DNA of the cell, while the contemporary anticancer drugs involve molecular-targeted therapy such as targeting the proteins possessing abnormal expression inside the cancer cells.

Share this post